Rapid-infusion rituximab in lymphoma treatment

被引：20

作者：

Provencio, M. ^{[1
]}

Cerdeira, S. ^{[1
]}

Bonilla, F. ^{[1
]}

Sanchez, A. ^{[1
]}

Espana, P. ^{[1
]}

机构：

[1] Hosp Univ Puerta Hierro, Med Oncol Serv, Madrid 28035, Spain

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷 / 06期

关键词：

D O I：

10.1093/annonc/mdj103

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1027 / U7

页数：2

共 6 条

[1] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[2] Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents [J].

Cragg, MS ;

Glennie, MJ .

BLOOD, 2004, 103 (07) :2738-2743

[3] Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte [J].

Feugier, P ;

Van Hoof, A ;

Sebban, C ;

Solal-Celigny, P ;

Bouabdallah, R ;

Fermé, C ;

Christian, B ;

Lepage, E ;

Tilly, H ;

Morschhauser, F ;

Gaulard, P ;

Salles, G ;

Bosly, A ;

Gisselbrecht, C ;

Reyes, F ;

Coiffier, B .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4117-4126

[4] CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma [J].

Marcus, R ;

Imrie, K ;

Belch, A ;

Cunningham, D ;

Flores, E ;

Catalano, J ;

Solal-Celigny, P ;

Offner, F ;

Walewski, J ;

Raposo, J ;

Jack, A ;

Smith, P .

BLOOD, 2005, 105 (04) :1417-1423

[5]

Sehn L, 2005, ANN ONCOL, V16, P69

[6] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance [J].

Smith, MR .

ONCOGENE, 2003, 22 (47) :7359-7368

← 1 →